Literature DB >> 12393438

The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation.

Stefan J Erkeland1, Marijke Valkhof, Claudia Heijmans-Antonissen, Ruud Delwel, Peter J M Valk, Mirjam H A Hermans, Ivo P Touw.   

Abstract

The genetic defects underlying the pathogenesis of acute myeloid leukemia (AML) are still largely unknown. Retroviral insertion mutagenesis in mice has become a powerful tool to identify candidate genes involved in the development of leukemia and lymphoma. We have used this strategy with the 1.4 strain of Graffi murine leukemia virus (MuLV), which predominantly causes myeloid leukemias. Here, we report that Graffi-1.4-induced AML frequently harbors virus integrations in the gene encoding the transcription factor Yin Yang 1 (YY1). These integrations occurred in both orientations, and all were located in the 5' promoter region of the gene, 0.5 to 1.5 kb upstream of the major transcriptional start site. Luciferase reporter assays showed that virus integration in this region increases promoter activity and renders it independent of a functional binding site for Sp1, a major transcriptional regulator of YY1. We used the murine 32D model to study the consequence of perturbed YY1 expression for myelopoiesis. YY1 protein levels were high in 32D parental cells maintained in interleukin-3-containing medium, but they dropped when the cells were induced to differentiate by granulocyte-colony-stimulating factor (G-CSF). Strikingly, G-CSF-induced neutrophilic differentiation was reduced in 32D cell transfectants ectopically expressing YY1. In similar experiments on primary bone marrow cells, enforced YY1 expression blocked the outgrowth of CFU-GM colonies. Increased YY1 expression was seen in some cases of human AML. Collectively, these data imply a possible role of perturbed expression of YY1 in the development of AML through interference with the myeloid differentiation program in the leukemic progenitor cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393438     DOI: 10.1182/blood-2002-04-1207

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

Review 1.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

Review 2.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

3.  Peroxiredoxin-controlled G-CSF signalling at the endoplasmic reticulum-early endosome interface.

Authors:  Karishma Palande; Onno Roovers; Judith Gits; Carola Verwijmeren; Yoshihito Iuchi; Junichi Fujii; Benjamin G Neel; Robert Karisch; Jan Tavernier; Ivo P Touw
Journal:  J Cell Sci       Date:  2011-11-01       Impact factor: 5.285

4.  YY1 is a novel potential therapeutic target for the treatment of HPV infection-induced cervical cancer by arsenic trioxide.

Authors:  Guifen He; Qian Wang; Yuqi Zhou; Xiaohua Wu; Lan Wang; Nadire Duru; Xiangtao Kong; Pingzhao Zhang; Bo Wan; Long Sui; Qisang Guo; Jian-Jian Li; Long Yu
Journal:  Int J Gynecol Cancer       Date:  2011-08       Impact factor: 3.437

5.  Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity.

Authors:  Taisuke Sawada; Chiharu Nishiyama; Takuma Kishi; Tomonari Sasazuki; Sachiko Komazawa-Sakon; Xin Xue; Jiang-Hu Piao; Hideko Ogata; Jun-ichi Nakayama; Tomohiko Taki; Yasuhide Hayashi; Mamoru Watanabe; Hideo Yagita; Ko Okumura; Hiroyasu Nakano
Journal:  J Biol Chem       Date:  2008-07-30       Impact factor: 5.157

6.  YY1 inhibits the activation of the p53 tumor suppressor in response to genotoxic stress.

Authors:  Eva Grönroos; Alexei A Terentiev; Tanel Punga; Johan Ericsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-04       Impact factor: 11.205

7.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

8.  A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.

Authors:  Carlos Riveros; Drew Mellor; Kaushal S Gandhi; Fiona C McKay; Mathew B Cox; Regina Berretta; S Yahya Vaezpour; Mario Inostroza-Ponta; Simon A Broadley; Robert N Heard; Stephen Vucic; Graeme J Stewart; David W Williams; Rodney J Scott; Jeanette Lechner-Scott; David R Booth; Pablo Moscato
Journal:  PLoS One       Date:  2010-12-01       Impact factor: 3.240

9.  The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.

Authors:  Vivian G Oehler; Katherine A Guthrie; Carrie L Cummings; Kathleen Sabo; Brent L Wood; Ted Gooley; Taimei Yang; Mirjam T Epping; Yaping Shou; Era Pogosova-Agadjanyan; Paula Ladne; Derek L Stirewalt; Janis L Abkowitz; Jerald P Radich
Journal:  Blood       Date:  2009-07-22       Impact factor: 22.113

10.  Suppressor of cytokine signaling 3 controls lysosomal routing of G-CSF receptor.

Authors:  Mahban I Irandoust; Lambertus H J Aarts; Onno Roovers; Judith Gits; Stefan J Erkeland; Ivo P Touw
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.